title: Successful sirolimus graded dose challenge in an erythromycin-allergic patient.
authors.forename: Jennifer W
authors.initials: JW
authors.lastname: Leiding
authors.forename: Thomas
authors.initials: T
authors.lastname: Hughes
authors.forename: Ashley
authors.initials: A
authors.lastname: Chasick
authors.forename: Ashley
authors.initials: A
authors.lastname: Chasik
authors.forename: Rachel B
authors.initials: RB
authors.lastname: Salit
mesh_terms: D000328:Adult; D004334:Drug Administration Schedule; D004917:Erythromycin / Q000009:adverse effects*; D005240:Feasibility Studies; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D015368:Human T-lymphotropic virus 1 / Q000276:immunology; D006801:Humans; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000188:drug therapy* / Q000276:immunology*; D012008:Recurrence; D020123:Sirolimus / Q000008:administration & dosage* / Q000627:therapeutic use*
chemical_list: D004917:Erythromycin; D020123:Sirolimus